Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter
- 28 January 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (4) , 1015-1022
- https://doi.org/10.1038/sj.onc.1202383
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 34 references indexed in Scilit:
- Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APLNature Genetics, 1998
- ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function.Genes & Development, 1997
- TEL‐AML1 fusion in acute lymphoblastic leukaemia of adultsBritish Journal of Haematology, 1996
- The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In VivoCell, 1996
- AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver HematopoiesisCell, 1996
- Regulation of granulocyte‐macrophage colony‐stimulating factor and interleukin 3 expressionThe International Journal of Cell Cloning, 1995
- Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocationCell, 1994
- Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid LeukemiaScience, 1993
- A simple phase-extraction assay for chloramphenicol acyltransferase activityGene, 1988
- Human IL-3 (multi-CSF): Identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3Cell, 1986